abstract |
Disclosed herein are N-naphthoylglycines and methods of their preparation. The N-naphthoylglycines are novel aldose reductase inhibitors useful for the treatment or prevention of diabetic complications and have the formula <CHEM> wherein R is fluorine, chlorine, bromine, lower alkoxy containing 1 to 5 carbon atoms, trifluoroethoxy, phenoxy or phenylmethoxy; X is =O, or =S; Y is -OH, -NH2 or -NHCO2CH2CH3, and the pharmaceutically acceptable salts thereof. |